Glyoxalase I: mechanism-based inhibitors

[Association between gross tumor regression patterns, distal resection margin distance, and local recurrence in rectal cancer after neoadjuvant therapy].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2026

A systematic review and meta synthesis of barriers and facilitators to Black women's participation in healthcare research.

BMC medical research methodology·2026

[Progress in research of multi-omics on risk for schizophrenia onset].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2025

[Progress in research of epidemiology of dyslipidemia and emerging risk factors].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2025

[Characteristics and management of perioperative complications in laparoscopic surgery for colorectal cancer patients aged over 85 years].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2025

[Clinical characteristics and prognosis of brain metastasis in locally advanced rectal cancer].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2024

Bioactivation and reactivity research advances - 2025 year in review.

Drug metabolism reviews·2026

Humanized mouse models for drug metabolism and drug transport: a systematic review.

Drug metabolism reviews·2026

Drug transporters in drug disposition - highlights from the year 2025.

Drug metabolism reviews·2026

Herbal supplements and anti-tuberculosis therapy: unlocking hidden interactions for better multidrug-resistant tuberculosis management.

Drug metabolism reviews·2026

Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometry.

Drug metabolism reviews·2026

Pharmacomicrobiomics in precision pharmacotherapy: bidirectional microbial-drug interactions as a key determinant of therapeutic response.

Drug metabolism reviews·2026

Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.

Journal of pharmaceutical analysis·2026

Design and optimization of nafimidone-inspired hybrid scaffolds targeting NaV1.2 for antiepileptic therapy with reduced cardiac liability.

Bioorganic chemistry·2026

Structure-informed characterization of a TLR2-binding scFv reveals a CDR-centered recognition model.

Biochemical and biophysical research communications·2026

Safety assessment of the substance 1,3-benzenedicarboxamide, 5-[[[cis-4-(1,1-dimethylethyl)cyclohexyl]carbonyl]amino]-N1,N3-bis[cis-4-(1-methylethyl)cyclohexyl]- for use in food contact materials.

EFSA journal. European Food Safety Authority·2026

Systems pharmacology, structural modeling, and experimental validation reveal retinoic acid as a modulator of immune-fibrotic networks in chronic kidney disease.

Naunyn-Schmiedeberg's archives of pharmacology·2026

New paradigm of q-CAR drug development targeting disease-specific protein conformations.

npj drug discovery·2026

Related Experiment Videos

Glyoxalase I: mechanism-based inhibitors

Related Concept Videos

[Association between gross tumor regression patterns, distal resection margin distance, and local recurrence in rectal cancer after neoadjuvant therapy].

A systematic review and meta synthesis of barriers and facilitators to Black women's participation in healthcare research.

[Progress in research of multi-omics on risk for schizophrenia onset].

[Progress in research of epidemiology of dyslipidemia and emerging risk factors].

[Characteristics and management of perioperative complications in laparoscopic surgery for colorectal cancer patients aged over 85 years].

[Clinical characteristics and prognosis of brain metastasis in locally advanced rectal cancer].

Bioactivation and reactivity research advances - 2025 year in review.

Humanized mouse models for drug metabolism and drug transport: a systematic review.

Drug transporters in drug disposition - highlights from the year 2025.

Herbal supplements and anti-tuberculosis therapy: unlocking hidden interactions for better multidrug-resistant tuberculosis management.

Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometry.

Pharmacomicrobiomics in precision pharmacotherapy: bidirectional microbial-drug interactions as a key determinant of therapeutic response.

Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.

Design and optimization of nafimidone-inspired hybrid scaffolds targeting NaV1.2 for antiepileptic therapy with reduced cardiac liability.

Structure-informed characterization of a TLR2-binding scFv reveals a CDR-centered recognition model.

Safety assessment of the substance 1,3-benzenedicarboxamide, 5-[[[cis-4-(1,1-dimethylethyl)cyclohexyl]carbonyl]amino]-N1,N3-bis[cis-4-(1-methylethyl)cyclohexyl]- for use in food contact materials.

Systems pharmacology, structural modeling, and experimental validation reveal retinoic acid as a modulator of immune-fibrotic networks in chronic kidney disease.

New paradigm of q-CAR drug development targeting disease-specific protein conformations.

Related Experiment Videos

Glyoxalase I: mechanism-based inhibitors

Related Concept Videos

Related Articles